Localization of KCNQ5 in the normal and epileptic human temporal neocortex and hippocampal formation

Neuroscience

Volumn 120, Issue 2, 2003, Pages 353-364

  Yus Najera E ^a   Munoz A ^a   Salvador, N ^a   Jensen, B S ^b   Rasmussen, H B ^c   Defelipe, J ^a   Villarroel, A ^a  

^a INSTITUTO CAJAL   (Spain)

^b NEUROSEARCH A S   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Epilepsy; Hippocampus; Human brain; KCNQ channels; M current; Neocortex

Indexed keywords

POTASSIUM CHANNEL; PROTEIN ANTIBODY; PROTEIN DERIVATIVE; PROTEIN KCNQ2; PROTEIN KCNQ3; PROTEIN KCNQ5; PROTEIN SUBUNIT; UNCLASSIFIED DRUG; HYBRID PROTEIN; KCNQ2 PROTEIN, HUMAN; KCNQ3 PROTEIN, HUMAN; KCNQ4 PROTEIN, HUMAN; KCNQ5 PROTEIN, HUMAN; POTASSIUM CHANNEL KCNQ; POTASSIUM CHANNEL KCNQ2; POTASSIUM CHANNEL KCNQ3; VOLTAGE GATED POTASSIUM CHANNEL;

ADOLESCENT; ADULT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CELL LOSS; CELL POPULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTRIC CURRENT; EPILEPSY; FEMALE; GLIA CELL; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; MALE; NEOCORTEX; NERVE EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PYRAMIDAL NERVE CELL; RAT; SCLEROSIS; TEMPORAL CORTEX; TISSUE DISTRIBUTION; WHITE MATTER; AGED; CELL LINE; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; FETUS; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; KIDNEY; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SERODIAGNOSIS; TEMPORAL LOBE; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; BLOTTING, WESTERN; CELL LINE; EPILEPSY; FEMALE; FETUS; FLUORESCENT ANTIBODY TECHNIQUE; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; KCNQ POTASSIUM CHANNELS; KCNQ2 POTASSIUM CHANNEL; KCNQ3 POTASSIUM CHANNEL; KIDNEY; MALE; MIDDLE AGED; POTASSIUM CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED; PRECIPITIN TESTS; RECOMBINANT FUSION PROTEINS; TEMPORAL LOBE; TRANSFECTION;

EID: 0141923490     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(03)00321-X     Document Type: Article

References (30)

1. Biervert C., Schroeder B.C., Kubisch C., Berkovic S.F., Propping P., Jentsch T.J., Steinlein O.K. A potassium channel mutation in neonatal human epilepsy. Science. 279:1998;403-406.
2. Brown D.A., Gahwiler B.H., Griffith W.H., Halliwell J.V. Membrane currents in hippocampal neurons. Prog Brain Res. 83:1990;141-160.
3. Charlier C., Singh N.A., Ryan S.G., Lewis T.B., Reus B.E., Leach R.J., Leppert M. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat Genet. 18:1998;53-55.
4. Cooper E.C., Aldape K.D., Abosch A., Barbaro N.M., Berger M.S., Peacock W.S., Jan Y.N., Jan L.Y. Colocalization and coassembly of two human brain M-type potassium channel subunits that are mutated in epilepsy. Proc Natl Acad Sci USA. 97:2000;4914-4919.
5. Cooper E.C., Harrington E., Jan Y.N., Jan L.Y. M Channel KCNQ2 subunits are localized to key sites for control of neuronal network oscillations and synchronization in mouse brain. J Neurosci. 21:2001;9529-9540.
6. De Strooper B., Beullens M., Contreras B., Levesque L., Craessaerts K., Cordell B., Moechars D., Bollen M., Fraser P., George-Hyslop P.S., Van Leuven F. Phosphorylation, subcellular localization, and membrane orientation of the Alzheimer's disease-associated presenilins. J Biol Chem. 272:1997;3590-3598.
7. Dedek K., Waldegger S. Colocalization of KCNQ1/KCNE channel subunits in the mouse gastrointestinal tract. Pflugers Arch. 442:2001;896-902.
8. Dupuis D.S., Schroder R.L., Jespersen T., Christensen J.K., Christophersen P., Jensen B.S., Olesen S.P. Activation of KCNQ5 channels stably expressed in HEK293 cells by BMS-204352. Eur J Pharmacol. 437:2002;129-137.
9. Engel J. Outcome with respect to epileptic seizures. Engel J. Surgical treatment of epilepsies. 1987;553-571 Raven Press, New York.
10. Gonzalez-Albo M.C., DeFelipe J. Colocalization of glutamate ionotropic receptor subunits in the human temporal neocortex. Cereb Cortex. 10:2000;621-631.
11. Gonzalez-Albo M.C., Gomez-Utrero E., Sanchez A., Sola R.G., DeFelipe J. Changes in the colocalization of glutamate ionotropic receptor subunits in the human epileptic temporal lobe cortex. Exp Brain Res. 138:2001;398-402.
12. Jentsch T.J. Neuronal KCNQ potassium channels physiology and role in disease . Nat Rev Neurosci. 1:2000;21-30.
13. + channel mutated in a form of dominant deafness, is expressed in the inner ear and the central auditory pathway. Proc Natl Acad Sci USA. 97:2000;4333-4338.
14. Kubisch C., Schroeder B.C., Friedrich T., Lutjohann B., El-Amraoui A., Marlin S., Petit C., Jentsch T.J. KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness. Cell. 96:1999;437-446.
15. Lerche C., Scherer C.R., Seebohm G., Derst C., Wei A.D., Busch A.E., Steinmeyer K. Molecular cloning and functional expression of KCNQ5, a potassium channel subunit that may contribute to neuronal M-current diversity. J Biol Chem. 275:2000;22395-22400.
16. Madison D.V., Nicoll R.A. Control of the repetitive discharge of rat CA 1 pyramidal neurones in vitro. J Physiol. 354:1984;319-331.
17. Marrion N.V. Control of M-current. Annu Rev Physiol. 59:1997;483-504.
18. BR1 receptor protein expression in human mesial temporal cortex changes in temporal lobe epilepsy . J Comp Neurol. 449:2002;166-179.
19. + channels and the molecular pathogenesis of epilepsy implications for therapy . Trends Neurosci. 23:2000;393-398.
20. + channels in brain. J Neurosci. 21:2001;4609-4624.
21. Schroeder B.C., Hechenberger M., Weinreich F., Kubisch C., Jentsch T.J. KCNQ5, a novel potassium channel broadly expressed in brain, mediates M-type currents. J Biol Chem. 275:2000;24089-24095.
22. + channels causes epilepsy. Nature. 396:1998;687-690.
23. Shah M.M., Mistry M., Marsh S.J., Brown D.A., Delmas P. Molecular correlates of the M-current in cultured rat hippocampal neurons. J Physiol. 544:2002;29-37.
24. Singh N.A., Charlier C., Stauffer D., DuPont B.R., Leach R.J., Melis R., Ronen G.M., Bjerre I., Quattlebaum T., Murphy J.V., McHarg M.L., Gagnon D., Rosales T.O., Peiffer A., Anderson V.E., Leppert M. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet. 18:1998;25-29.
25. Sogaard R., Ljungstrom T., Pedersen K.A., Olesen S.P., Jensen B.S. KCNQ4 channels expressed in mammalian cells functional characteristics and pharmacology . Am J Physiol Cell Physiol. 280:2001;C859-C866.
26. Steinlein O.K. Gene defects in idiopathic epilepsy. Rev Neurol (Paris). 155:1999;450-453.
27. Tinel N., Lauritzen I., Chouabe C., Lazdunski M., Borsotto M. The KCNQ2 potassium channel splice variants, functional and developmental expression: brain localization and comparison with KCNQ3 . FEBS Lett. 438:1998;171-176.
28. Wang H.S., Pan Z., Shi W., Brown B.S., Wymore R.S., Cohen I.S., Dixon J.E., McKinnon D. KCNQ2 and KCNQ3 potassium channel subunits molecular correlates of the M-channel . Science. 282:1998;1890-1893.
29. Wickenden A.D., Zou A., Wagoner P.K., Jegla T. Characterization of KCNQ5/Q3 potassium channels expressed in mammalian cells. Br J Pharmacol. 132:2001;381-384.
30. Yus-Najera E., Santana-Castro I., Villarroel A. The identification and characterization of a noncontinuous calmodulin-binding site in noninactivating voltage-dependent KCNQ potassium channels. J Biol Chem. 277:2002;28545-28553.